112 related articles for article (PubMed ID: 32620657)
21. Tumor size does not predict risk of metastatic disease or prognosis of small renal cell carcinomas.
Klatte T; Patard JJ; de Martino M; Bensalah K; Verhoest G; de la Taille A; Abbou CC; Allhoff EP; Carrieri G; Riggs SB; Kabbinavar FF; Belldegrun AS; Pantuck AJ
J Urol; 2008 May; 179(5):1719-26. PubMed ID: 18343437
[TBL] [Abstract][Full Text] [Related]
22. Decreased ARID1A expression correlates with poor prognosis of clear cell renal cell carcinoma.
Park JH; Lee C; Suh JH; Chae JY; Kim HW; Moon KC
Hum Pathol; 2015 Mar; 46(3):454-60. PubMed ID: 25628030
[TBL] [Abstract][Full Text] [Related]
23. The diagnosis of renal cell cancer in relation to hypertension (United States).
Rosenberg L; Stephenson WP; Rao RS; Palmer JR; Strom BL; Shapiro S
Cancer Causes Control; 1998 Dec; 9(6):611-4. PubMed ID: 10189046
[TBL] [Abstract][Full Text] [Related]
24. [Relationship of renal cell carcinoma and hypertension].
Masanauskiene E; Naudziūnas A; Jankauskiene L; Unikauskas A
Medicina (Kaunas); 2009; 45(12):1019-21. PubMed ID: 20173406
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Impact of Renin-Angiotensin System Blockade on Renal Cell Carcinoma After Surgery.
Miyajima A; Yazawa S; Kosaka T; Tanaka N; Shirotake S; Mizuno R; Kikuchi E; Oya M
Ann Surg Oncol; 2015 Oct; 22(11):3751-9. PubMed ID: 25691280
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of body mass index in Korean patients with renal cell carcinoma.
Jeon HG; Jeong IG; Lee JH; Lee CJ; Kwak C; Kim HH; Lee SE; Lee E
J Urol; 2010 Feb; 183(2):448-54. PubMed ID: 20006879
[TBL] [Abstract][Full Text] [Related]
27. Impact of weather on presentation of kidney tumour: a thirteen years retrospective study.
Agha F; Anwar K; Akhter N
J Pak Med Assoc; 2002 Oct; 52(10):447-50. PubMed ID: 12553672
[TBL] [Abstract][Full Text] [Related]
28. Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma.
Chen K; Lee BL; Huang HH; Tan BY; Lee LS; Ng LG; Lau W; Yuen JS
Int J Urol; 2017 Jan; 24(1):51-58. PubMed ID: 27757999
[TBL] [Abstract][Full Text] [Related]
29. Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma.
Dall'Oglio MF; Ribeiro-Filho LA; Antunes AA; Crippa A; Nesrallah L; Gonçalves PD; Leite KR; Srougi M
J Urol; 2007 Aug; 178(2):425-8; discussion 428. PubMed ID: 17561167
[TBL] [Abstract][Full Text] [Related]
30. Multilocular Cystic Renal Cell Neoplasm of Low Malignant Potential: A Series of 76 Cases.
Li T; Chen J; Jiang Y; Ning X; Peng S; Wang J; He Q; Yang X; Gong K
Clin Genitourin Cancer; 2016 Dec; 14(6):e553-e557. PubMed ID: 27108004
[TBL] [Abstract][Full Text] [Related]
31. Renal sinus fat invasion in pT3a clear cell renal cell carcinoma affects outcomes of patients without nodal involvement or distant metastases.
Bertini R; Roscigno M; Freschi M; Strada E; Petralia G; Pasta A; Matloob R; Sozzi F; Da Pozzo L; Colombo R; Guazzoni G; Doglioni C; Montorsi F; Rigatti P
J Urol; 2009 May; 181(5):2027-32. PubMed ID: 19286201
[TBL] [Abstract][Full Text] [Related]
32. The impact of three-dimensional tumor volume on cancer-specific survival for patients with pT1 clear-cell renal cell carcinoma.
Song W; Jeong BC; Seo SI; Jeon SS; Lee HM; Choi HY; Jeon HG
World J Urol; 2016 Jan; 34(1):83-8. PubMed ID: 25981404
[TBL] [Abstract][Full Text] [Related]
33. Epidemiology, clinical staging, and presentation of renal cell carcinoma.
Decastro GJ; McKiernan JM
Urol Clin North Am; 2008 Nov; 35(4):581-92; vi. PubMed ID: 18992612
[TBL] [Abstract][Full Text] [Related]
34. Prognostic factors for renal cell carcinoma with tumor thrombus extension.
Klatte T; Pantuck AJ; Riggs SB; Kleid MD; Shuch B; Zomorodian N; Kabbinavar FF; Belldegrun AS
J Urol; 2007 Oct; 178(4 Pt 1):1189-95; discussion 1195. PubMed ID: 17698087
[TBL] [Abstract][Full Text] [Related]
35. High Occurrence of Non-Clear Cell Renal Cell Carcinoma in Oman.
Venniyoor A; Essam AM; Ramadhan F; Keswani H; Mehdi I; Bahrani BA
Asian Pac J Cancer Prev; 2016; 17(6):2801-4. PubMed ID: 27356693
[TBL] [Abstract][Full Text] [Related]
36. Checkpoint inhibitors in patients with metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.
Yip SM; Wells C; Moreira R; Wong A; Srinivas S; Beuselinck B; Porta C; Sim HW; Ernst DS; Rini BI; Yuasa T; Basappa NS; Kanesvaran R; Wood LA; Canil C; Kapoor A; Fu SYF; Choueiri TK; Heng DYC
Cancer; 2018 Sep; 124(18):3677-3683. PubMed ID: 30307610
[TBL] [Abstract][Full Text] [Related]
37. [Characteristics of incidentally detected renal cell carcinoma by ultrasonography at health check-up].
Shintaku I; Suzuki Y; Uchi K; Morita M; Terasawa Y
Nihon Hinyokika Gakkai Zasshi; 2000 Feb; 91(2):43-8. PubMed ID: 10723175
[TBL] [Abstract][Full Text] [Related]
38. Renal cell carcinoma in kidney transplant recipients: descriptive analysis and overview of a major German transplant center.
Eggers H; Güler F; Ehlers U; Ivanyi P; Peters I; Grünwald V
Future Oncol; 2019 Nov; 15(32):3739-3750. PubMed ID: 31664864
[No Abstract] [Full Text] [Related]
39. Low CCL-21 expression associates with unfavorable postoperative prognosis of patients with metastatic renal cell carcinoma.
Xiong Y; Liu L; Wang J; Xi W; Xia Y; Bai Q; Qu Y; Long Q; Xu J; Guo J
Oncotarget; 2017 Apr; 8(15):25650-25659. PubMed ID: 27783999
[TBL] [Abstract][Full Text] [Related]
40. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
Pan D; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
